BIOPHEN Heparin Anti-Xa (2 stages) - Replaced by A221005

BIOPHEN Heparin Anti-Xa (2 stages) - Replaced by A221005

Code: A221010-USP
Manufacturer’s Part Number: 221010
Product size: Kit

Price: $350.00


Product Description

This product has been updated and replaced with two products, A221005 (reagents) and AAR030K (buffer).

Chromogenic anti-Xa method for measuring homogeneously heparin in plasma (tested diluted 1:10) or in purified systems, using a two stage method. Offers a wide measurement range from 0 to 1 IU/mL for plasma, or from 0.005 to 0.10 IU/mL for purified systems and is appropriate for testing heparins for their anti-FXa activity. This assay is in compliance with USP Anti-FXa assay for unfractionated heparin.

Please see important notification letter from the manufacturer regarding the use of this product.

Product Characteristics

  • Total Assay Time: < 5 min
  • Detection Threshold: < 0.1 IU/mL
  • Dynamic Range: 0 to 1 IU/mL
  • Dynamic Range When Diluted: 0 to 0.1 IU/mL
  • Intra-Assay CV: < 3%
  • Inter-Assay CV: < 5%
  • Number of Tests (Manual Microplate Method): 2 x 100 Tests

Product Components

  • R1: 2 x 1 mL ATIII
  • R2: 2 x 1 mL FXa
  • R3: 2 x 5 mL FXa substrate (SXa-11)
  • R4: 4 x 25 mL Reaction buffer

Product Applications

For the measurement of anti-Xa Heparin activity in research applications.

This assay, using a predilution of Antithrombin and FXa reagents in R4 buffer, is in compliance with the USP Anti-Factor Xa assay for unfractionated heparin.

Please Note: Results obtained should be for research purposes only and not used for patient diagnosis or treatment.

Instructions For Use

Material Safety Data Sheet (MSDS)

Technical Data

Other Documents